Correlation Between Par Drugs and DiGiSPICE Technologies

Can any of the company-specific risk be diversified away by investing in both Par Drugs and DiGiSPICE Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Par Drugs and DiGiSPICE Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Par Drugs And and DiGiSPICE Technologies Limited, you can compare the effects of market volatilities on Par Drugs and DiGiSPICE Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Par Drugs with a short position of DiGiSPICE Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Par Drugs and DiGiSPICE Technologies.

Diversification Opportunities for Par Drugs and DiGiSPICE Technologies

-0.52

Correlation Coefficient

Par Drugs  DiGiSPICE Technologies

Excellent diversification

The 3 months correlation between Par and DiGiSPICE is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Par Drugs And and DiGiSPICE Technologies Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DiGiSPICE Technologies and Par Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Par Drugs And are associated (or correlated) with DiGiSPICE Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DiGiSPICE Technologies has no effect on the direction of Par Drugs i.e., Par Drugs and DiGiSPICE Technologies go up and down completely randomly.

Pair Corralation between Par Drugs and DiGiSPICE Technologies

Assuming the 90 days trading horizon Par Drugs is expected to generate 4.48 times less return on investment than DiGiSPICE Technologies. But when comparing it to its historical volatility, Par Drugs And is 2.04 times less risky than DiGiSPICE Technologies. It trades about 0.03 of its potential returns per unit of risk. DiGiSPICE Technologies Limited is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  2,009  in DiGiSPICE Technologies Limited on April 20, 2025 and sell it today you would earn a total of  234.00  from holding DiGiSPICE Technologies Limited or generate 11.65% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Par Drugs And  vs.  DiGiSPICE Technologies Limited

Par Drugs And

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Par Drugs And are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound technical and fundamental indicators, Par Drugs is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

DiGiSPICE Technologies

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in DiGiSPICE Technologies Limited are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak forward indicators, DiGiSPICE Technologies demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Par Drugs and DiGiSPICE Technologies

The main advantage of trading using opposite Par Drugs and DiGiSPICE Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Par Drugs position performs unexpectedly, DiGiSPICE Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DiGiSPICE Technologies will offset losses from the drop in DiGiSPICE Technologies' long position.

The idea behind Par Drugs And and DiGiSPICE Technologies Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.